Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Joshua Korzenik, M.D.


Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Jactel SN, Olson JM, Wolin KY, Brown J, Pathipati MP, Jagiella VJ, Korzenik JR. Efficacy of a Digital Personalized Elimination Diet for the Self-Management of Irritable Bowel Syndrome and Comorbid Irritable Bowel Syndrome and Inflammatory Bowel Disease. Clin Transl Gastroenterol. 2023 01 01; 14(1):e00545. PMID: 36322404; PMCID: PMC9875997.
    Citations:    Fields:    Translation:Humans
  2. Maratt JK, Siegel CA, Barkun AN, Bouhnik Y, Bressler B, Calderwood AH, East JE, Fischer M, Grossmann J, Korzenik JR, Menees SB, Panes J, Rex DK, Sey MSL, Allio MK, Baker KA, Guizzetti L, Remillard J, Sedano R, Feagan BG, Ma C, Jairath V. An Expert Consensus to Standardize Assessment of Bowel Cleansing for Clinical Trials of Bowel Preparations for Crohn's Disease. Dig Dis Sci. 2022 Nov 27. PMID: 36436154.
    Citations:    Fields:    
  3. Zisman-Ilani Y, Thompson KD, Siegel LS, Mackenzie T, Crate DJ, Korzenik JR, Melmed GY, Kozuch P, Sands BE, Rubin DT, Regueiro MD, Cross R, Wolf DC, Hanson JS, Schwartz RM, Vrabie R, Kreines MD, Scherer T, Dubinsky MC, Siegel CA. Crohn's disease shared decision making intervention leads to more patients choosing combination therapy: a cluster randomised controlled trial. Aliment Pharmacol Ther. 2023 01; 57(2):205-214. PMID: 36377259; PMCID: PMC9790033.
    Citations:    Fields:    Translation:Humans
  4. Sanmarco LM, Chao CC, Wang YC, Kenison JE, Li Z, Rone JM, Rejano-Gordillo CM, Polonio CM, Gutierrez-Vazquez C, Piester G, Plasencia A, Li L, Giovannoni F, Lee HG, Faust Akl C, Wheeler MA, Mascanfroni I, Jaronen M, Alsuwailm M, Hewson P, Yeste A, Andersen BM, Franks DG, Huang CJ, Ekwudo M, Tjon EC, Rothhammer V, Takenaka M, de Lima KA, Linnerbauer M, Guo L, Covacu R, Queva H, Fonseca-Castro PH, Bladi MA, Cox LM, Hodgetts KJ, Hahn ME, Mildner A, Korzenik J, Hauser R, Snapper SB, Quintana FJ. Identification of environmental factors that promote intestinal inflammation. Nature. 2022 11; 611(7937):801-809. PMID: 36266581; PMCID: PMC9898826.
    Citations: 5     Fields:    Translation:AnimalsCells
  5. Gandhi S, Zelman S, De Armas RE, Hemond C, Levy AN, Singh S, Korzenik J, Jangi S. Natural History of New-onset Inflammatory Bowel Disease Among Patients With Multiple Sclerosis. Inflamm Bowel Dis. 2022 10 03; 28(10):1614-1617. PMID: 35348692; PMCID: PMC9527605.
    Citations:    Fields:    Translation:Humans
  6. Kang YH, Tucker SA, Quevedo SF, Inal A, Korzenik JR, Haigis MC. Metabolic analyses reveal dysregulated NAD+ metabolism and altered mitochondrial state in ulcerative colitis. PLoS One. 2022; 17(8):e0273080. PMID: 35976971; PMCID: PMC9385040.
    Citations: 1     Fields:    Translation:HumansCells
  7. Huang HW, Ehmke C, Steiger C, Ballinger I, Jimenez M, Phan N, Sun H, Ishida K, Kuosmanen J, Jenkins J, Korzenik J, Hayward A, Traverso G. In Situ Detection of Gastrointestinal Inflammatory Biomarkers Using Electrochemical Gas Sensors. Annu Int Conf IEEE Eng Med Biol Soc. 2022 07; 2022:2491-2494. PMID: 36085797.
    Citations: 1     Fields:    Translation:Animals
  8. Cross RK, Naegeli AN, Harrison RW, Moore PC, Mackey RH, Crabtree MM, Lemay CA, Arora V, Morris N, Sontag A, Kayhan C, Korzenik JR. Disease Burden and Patient-Reported Outcomes Among Ulcerative Colitis Patients According to Therapy at Enrollment Into CorEvitas' Inflammatory Bowel Disease Registry. Crohns Colitis 360. 2022 Jul; 4(3):otac007. PMID: 36777423; PMCID: PMC9802151.
  9. Raffals LE, Saha S, Bewtra M, Norris C, Dobes A, Heller C, O'Charoen S, Fehlmann T, Sweeney S, Weaver A, Bishu S, Cross R, Dassopoulos T, Fischer M, Yarur A, Hudesman D, Parakkal D, Duerr R, Caldera F, Korzenik J, Pekow J, Wells K, Bohm M, Perera L, Kaur M, Ciorba M, Snapper S, Scoville EA, Dalal S, Wong U, Lewis JD. The Development and Initial Findings of A Study of a Prospective Adult Research Cohort with Inflammatory Bowel Disease (SPARC IBD). Inflamm Bowel Dis. 2022 02 01; 28(2):192-199. PMID: 34436563; PMCID: PMC9013198.
    Citations: 1     Fields:    Translation:Humans
  10. Allegretti JR, Canakis A, McClure E, Marcus J, Norton BA, Hamilton MJ, Winter RW, De Silva PS, Friedman S, Korzenik JR. Infliximab De-escalation in Patients With Crohn's Disease in Clinical Remission Is Safe and Well-tolerated. Inflamm Bowel Dis. 2021 11 15; 27(12):2031-2033. PMID: 34142700.
    Citations:    Fields:    Translation:Humans
  11. Steiger C, Phan NV, Sun H, Huang HW, Hess K, Lopes A, Korzenik J, Langer R, Traverso G. Controlled Delivery of Bile Acids to the Colon. Clin Transl Gastroenterol. 2020 12; 11(12):e00229. PMID: 33512801; PMCID: PMC7710212.
    Citations: 3     Fields:    Translation:HumansAnimalsCells
  12. Jangi S, Ruan A, Korzenik J, de Silva P. South Asian Patients With Inflammatory Bowel Disease in the United States Demonstrate More Fistulizing and Perianal Crohn Phenotype. Inflamm Bowel Dis. 2020 11 19; 26(12):1933-1942. PMID: 32115633.
    Citations: 8     Fields:    Translation:Humans
  13. Zhang S, Cho WJ, Jin AT, Kok LY, Shi Y, Heller DE, Lee YL, Zhou Y, Xie X, Korzenik JR, Lennerz JK, Traverso G. Heparin-Coated Albumin Nanoparticles for Drug Combination in Targeting Inflamed Intestine. Adv Healthc Mater. 2020 08; 9(16):e2000536. PMID: 32597571.
    Citations: 5     Fields:    Translation:HumansAnimals
  14. Barnes EL, Kochar B, Herfarth HH, Winter RW, Long MD, Korzenik JR, Quevedo SF, Galanko JA, Koruda M, Kappelman MD, Sandler RS. Creation of a Case-Finding Definition for Identifying Patients With Acute Pouchitis in Administrative Claims Data. Clin Gastroenterol Hepatol. 2021 04; 19(4):842-844.e1. PMID: 32147595.
    Citations: 2     Fields:    Translation:Humans
  15. Korzenik J, Larsen MD, Nielsen J, Kjeldsen J, Nørgård BM. Editorial: anti-TNF therapy-a double-edged sword? Authors' reply. Aliment Pharmacol Ther. 2019 10; 50(7):823-824. PMID: 31532552.
    Citations:    Fields:    Translation:Humans
  16. Korzenik J, Larsen MD, Nielsen J, Kjeldsen J, Nørgård BM. Increased risk of developing Crohn's disease or ulcerative colitis in 17 018 patients while under treatment with anti-TNFa agents, particularly etanercept, for autoimmune diseases other than inflammatory bowel disease. Aliment Pharmacol Ther. 2019 08; 50(3):289-294. PMID: 31267570.
    Citations: 23     Fields:    Translation:Humans
  17. Allegretti JR, Kassam Z, Carrellas M, Mullish BH, Marchesi JR, Pechlivanis A, Smith M, Gerardin Y, Timberlake S, Pratt DS, Korzenik JR. Fecal Microbiota Transplantation in Patients With Primary Sclerosing Cholangitis: A Pilot Clinical Trial. Am J Gastroenterol. 2019 07; 114(7):1071-1079. PMID: 30730351.
    Citations: 59     Fields:    Translation:HumansCTClinical Trials
  18. Boden EK, Canavan JB, Moran CJ, McCann K, Dunn WA, Farraye FA, Ananthakrishnan AN, Yajnik V, Gandhi R, Nguyen DD, Bhan AK, Weiner HL, Korzenik JR, Snapper SB. Immunologic Alterations Associated With Oral Delivery of Anti-CD3 (OKT3) Monoclonal Antibodies in Patients With Moderate-to-Severe Ulcerative Colitis. Crohns Colitis 360. 2019 Jul; 1(2):otz009. PMID: 31423487; PMCID: PMC6690423.
    Citations: 10     
  19. Ho SM, Lewis JD, Mayer EA, Plevy SE, Chuang E, Rappaport SM, Croitoru K, Korzenik JR, Krischer J, Hyams JS, Judson R, Kellis M, Jerrett M, Miller GW, Grant ML, Shtraizent N, Honig G, Hurtado-Lorenzo A, Wu GD. Challenges in IBD Research: Environmental Triggers. Inflamm Bowel Dis. 2019 05 16; 25(Suppl 2):S13-S23. PMID: 31095702; PMCID: PMC6787673.
    Citations: 32     Fields:    Translation:HumansPHPublic Health
  20. Korzenik J. Don't Worry, Be Happy: Psychological Interventions in Inflammatory Bowel Disease. Gastroenterology. 2019 03; 156(4):856-857. PMID: 30776343.
    Citations: 4     Fields:    Translation:Humans
  21. Ouahed J, Gordon W, Canavan JB, Zhou H, Du S, von Schack D, Phillips K, Wang L, Dunn WA, Field M, Friel S, Griffith A, Evans S, Tollefson S, Carrellas M, Cao B, Merker A, Bousvaros A, Shouval DS, Hung K, Lepsy C, Afzelius L, Korzenik JR, Snapper SB. Mucosal Gene Expression in Pediatric and Adult Patients With Ulcerative Colitis Permits Modeling of Ideal Biopsy Collection Strategy for Transcriptomic Analysis. Inflamm Bowel Dis. 2018 11 29; 24(12):2565-2578. PMID: 30085215; PMCID: PMC6265054.
    Citations: 7     Fields:    Translation:Humans
  22. de Silva PS, O'Toole A, Marc LG, Ulysse CA, Testa MA, Julsgaard M, Ngyuen D, Ananthakrishnan A, Laursen T, Højgaard A, Christensen LA, Korzenik J, Friedman S. Development of a Sexual Dysfunction Scale for Women With Inflammatory Bowel Disease. Inflamm Bowel Dis. 2018 10 12; 24(11):2350-2359. PMID: 30165525; PMCID: PMC6185125.
    Citations: 7     Fields:    Translation:Humans
  23. Merker AM, Riaz M, Friedman S, Allegretti JR, Korzenik J. Legalization of Medicinal Marijuana Has Minimal Impact on Use Patterns in Patients With Inflammatory Bowel Disease. Inflamm Bowel Dis. 2018 10 12; 24(11):2309-2314. PMID: 29788102.
    Citations: 7     Fields:    Translation:Humans
  24. Nassan FL, Korevaar TIM, Coull BA, Skakkebæk NE, Krawetz SA, Estill M, Hait EJ, Korzenik JR, Ford JB, De Poortere RA, Broeren MA, Moss AC, Zoeller TR, Hauser R. Dibutyl-phthalate exposure from mesalamine medications and serum thyroid hormones in men. Int J Hyg Environ Health. 2019 01; 222(1):101-110. PMID: 30170956.
    Citations: 7     Fields:    Translation:Humans
  25. Han L, Maciejewski M, Brockel C, Gordon W, Snapper SB, Korzenik JR, Afzelius L, Altman RB. A probabilistic pathway score (PROPS) for classification with applications to inflammatory bowel disease. Bioinformatics. 2018 03 15; 34(6):985-993. PMID: 29048458.
    Citations: 13     Fields:    Translation:Humans
  26. O'Toole A, de Silva PS, Marc LG, Ulysse CA, Testa MA, Ting A, Moss A, Korzenik J, Friedman S. Sexual Dysfunction in Men With Inflammatory Bowel Disease: A New IBD-Specific Scale. Inflamm Bowel Dis. 2018 01 18; 24(2):310-316. PMID: 29361102; PMCID: PMC6014620.
    Citations: 13     Fields:    Translation:Humans
  27. Marchioni Beery RM, Barnes EL, Nadkarni A, Korzenik JR. Suicidal Behavior Among Hospitalized Adults With Inflammatory Bowel Disease: A United States Nationwide Analysis. Inflamm Bowel Dis. 2017 12 19; 24(1):25-34. PMID: 29272476.
    Citations: 2     Fields:    Translation:Humans
  28. Winter RW, Korzenik JR. The Practical Pros and Cons of Complementary and Alternative Medicine in Practice: Integrating Complementary and Alternative Medicine into Clinical Care. Gastroenterol Clin North Am. 2017 12; 46(4):907-916. PMID: 29173531.
    Citations: 2     Fields:    Translation:Humans
  29. Barnes EL, Kochar B, Long MD, Martin CF, Crockett SD, Korzenik JR, Kappelman MD. The Burden of Hospital Readmissions among Pediatric Patients with Inflammatory Bowel Disease. J Pediatr. 2017 12; 191:184-189.e1. PMID: 29037795; PMCID: PMC5792080.
    Citations: 5     Fields:    Translation:Humans
  30. Nassan FL, Coull BA, Skakkebaek NE, Andersson AM, Williams MA, Mínguez-Alarcón L, Krawetz SA, Hall JE, Hait EJ, Korzenik JR, Ford JB, Moss AC, Hauser R. A crossover-crossback prospective study of dibutyl-phthalate exposure from mesalamine medications and serum reproductive hormones in men. Environ Res. 2018 01; 160:121-131. PMID: 28978458; PMCID: PMC5705343.
    Citations: 5     Fields:    Translation:Humans
  31. de Silva PS, Yang X, Korzenik JR, Goldman RH, Arheart KL, Caban-Martinez AJ. Association of urinary phenolic compounds, inflammatory bowel disease and chronic diarrheal symptoms: Evidence from the National Health and Nutrition Examination Survey. Environ Pollut. 2017 Oct; 229:621-626. PMID: 28689150.
    Citations: 7     Fields:    Translation:HumansPHPublic Health
  32. Korzenik J, Koch AK, Langhorst J. Complementary and Integrative Gastroenterology. Med Clin North Am. 2017 Sep; 101(5):943-954. PMID: 28802472.
    Citations: 1     Fields:    Translation:Humans
  33. Barnes EL, Kochar B, Long MD, Kappelman MD, Martin CF, Korzenik JR, Crockett SD. Modifiable Risk Factors for Hospital Readmission Among Patients with Inflammatory Bowel Disease in a Nationwide Database. Inflamm Bowel Dis. 2017 06; 23(6):875-881. PMID: 28426473; PMCID: PMC5512697.
    Citations: 28     Fields:    Translation:Humans
  34. Solomon DH, Shadick NA, Weinblatt ME, Frits M, Iannaccone C, Zak A, Korzenik JR. Clinical patient registry recruitment and retention: a survey of patients in two chronic disease registries. BMC Med Res Methodol. 2017 Apr 17; 17(1):59. PMID: 28415991.
    Citations: 4     Fields:    Translation:Humans
  35. Allegretti JR, Barnes EL, Stevens B, Storm M, Ananthakrishnan A, Yajnik V, Korzenik J. Predictors of Clinical Response and Remission at 1 Year Among a Multicenter Cohort of Patients with Inflammatory Bowel Disease Treated with Vedolizumab. Dig Dis Sci. 2017 06; 62(6):1590-1596. PMID: 28357697; PMCID: PMC5661939.
    Citations: 19     Fields:    Translation:Humans
  36. Kuo B, Bhasin M, Jacquart J, Scult MA, Slipp L, Riklin EI, Lepoutre V, Comosa N, Norton BA, Dassatti A, Rosenblum J, Thurler AH, Surjanhata BC, Hasheminejad NN, Kagan L, Slawsby E, Rao SR, Macklin EA, Fricchione GL, Benson H, Libermann TA, Korzenik J, Denninger JW. Correction: Genomic and Clinical Effects Associated with a Relaxation Response Mind-Body Intervention in Patients with Irritable Bowel Syndrome and Inflammatory Bowel Disease. PLoS One. 2017; 12(2):e0172872. PMID: 28222181.
    Citations:    Fields:    
  37. Goettel J, Kotlarz D, Illig D, Canavan J, Allegretti J, Hamilton M, Kelly R, Griffith A, Carellas M, Nelina A, Bousvaros A, Korzenik J, Snapper S. O-011 Low-dose IL-2 Administration Expands Human Regulatory T Cells in Patients with UC and Humanized Mice and Protects Against Experimental Colitis. Inflamm Bowel Dis. 2017 Feb; 23 Suppl 1:S4. PMID: 28125559.
  38. Barnes EL, Nestor M, Onyewadume L, de Silva PS, Korzenik JR. High Dietary Intake of Specific Fatty Acids Increases Risk of Flares in Patients With Ulcerative Colitis in Remission During Treatment With Aminosalicylates. Clin Gastroenterol Hepatol. 2017 Sep; 15(9):1390-1396.e1. PMID: 28110099; PMCID: PMC5515695.
    Citations: 23     Fields:    Translation:Humans
  39. Winter RW, Collins E, Cao B, Carrellas M, Crowell AM, Korzenik JR. Higher 25-hydroxyvitamin D levels are associated with greater odds of remission with anti-tumour necrosis factor-a medications among patients with inflammatory bowel diseases. Aliment Pharmacol Ther. 2017 03; 45(5):653-659. PMID: 28074487; PMCID: PMC5290123.
    Citations: 28     Fields:    Translation:Humans
  40. Barnes EL, Goldin A, Winter RW, Collins E, Cao B, Carrellas M, Crowell AM, Korzenik JR. Sequential Combination Therapy Versus Monotherapy: A Lack of Benefit in Time to Inflammatory Bowel Disease-Related Surgery. Dig Dis Sci. 2016 11; 61(11):3261-3269. PMID: 27639871; PMCID: PMC5512691.
    Citations: 1     Fields:    Translation:Humans
  41. Vaughn BP, Vatanen T, Allegretti JR, Bai A, Xavier RJ, Korzenik J, Gevers D, Ting A, Robson SC, Moss AC. Increased Intestinal Microbial Diversity Following Fecal Microbiota Transplant for Active Crohn's Disease. Inflamm Bowel Dis. 2016 09; 22(9):2182-90. PMID: 27542133; PMCID: PMC4995064.
    Citations: 89     Fields:    Translation:HumansCells
  42. Barnes EL, Beery RM, Schulman AR, McCarthy EP, Korzenik JR, Winter RW. Hospitalizations for Acute Myocardial Infarction Are Decreased Among Patients with Inflammatory Bowel Disease Using a Nationwide Inpatient Database. Inflamm Bowel Dis. 2016 09; 22(9):2229-37. PMID: 27542135; PMCID: PMC6044732.
    Citations: 14     Fields:    Translation:Humans
  43. Nassan FL, Coull BA, Skakkebaek NE, Williams MA, Dadd R, Mínguez-Alarcón L, Krawetz SA, Hait EJ, Korzenik JR, Moss AC, Ford JB, Hauser R. A crossover-crossback prospective study of dibutyl-phthalate exposure from mesalamine medications and semen quality in men with inflammatory bowel disease. Environ Int. 2016 Oct; 95:120-30. PMID: 27575365.
    Citations: 13     Fields:    Translation:Humans
  44. Marchioni Beery RM, Korzenik JR. Crohn's Cartography: Mapping Disease Patterns and Trajectories Using the Lémann Index-Are We Finding Our Way? J Clin Gastroenterol. 2016 07; 50(6):441-4. PMID: 27159423.
    Citations:    Fields:    Translation:Humans
  45. Allegretti JR, Kearney S, Li N, Bogart E, Bullock K, Gerber GK, Bry L, Clish CB, Alm E, Korzenik JR. Recurrent Clostridium difficile infection associates with distinct bile acid and microbiome profiles. Aliment Pharmacol Ther. 2016 06; 43(11):1142-53. PMID: 27086647; PMCID: PMC5214573.
    Citations: 70     Fields:    Translation:HumansCells
  46. Lennerz JK, van der Sloot KWJ, Le LP, Batten JM, Han JY, Fan KC, Siegel CA, Srivastava A, Park DY, Chen JH, Sands BE, Korzenik JR, Odze RD, Dias-Santagata D, Borger DR, Khalili H, Iafrate AJ, Lauwers GY. Colorectal cancer in Crohn's colitis is comparable to sporadic colorectal cancer. Int J Colorectal Dis. 2016 05; 31(5):973-982. PMID: 27026089.
    Citations: 15     Fields:    Translation:HumansCells
  47. O'Toole A, Lucci M, Korzenik J. Inflammatory Bowel Disease Provoked by Etanercept: Report of 443 Possible Cases Combined from an IBD Referral Center and the FDA. Dig Dis Sci. 2016 06; 61(6):1772-4. PMID: 26728477.
    Citations: 22     Fields:    Translation:Humans
  48. Dossett ML, Korzenik JR, Baim M, Denninger JW, Mehta DH. A Case Report of Improvement in Crohn's Disease-related Symptoms Following Participation in a Comprehensive Mind-Body Program. Glob Adv Health Med. 2016 Jan; 5(1):122-5. PMID: 26937324; PMCID: PMC4756789.
    Citations: 2     
  49. Konijeti GG, Arora P, Boylan MR, Song Y, Huang S, Harrell F, Newton-Cheh C, O'Neill D, Korzenik J, Wang TJ, Chan AT. Vitamin D Supplementation Modulates T Cell-Mediated Immunity in Humans: Results from a Randomized Control Trial. J Clin Endocrinol Metab. 2016 Feb; 101(2):533-8. PMID: 26653112; PMCID: PMC4880125.
    Citations: 19     Fields:    Translation:HumansCells
  50. Shelton E, Allegretti JR, Stevens B, Lucci M, Khalili H, Nguyen DD, Sauk J, Giallourakis C, Garber J, Hamilton MJ, Tomczak M, Makrauer F, Burakoff RB, Levine J, de Silva P, Friedman S, Ananthakrishnan A, Korzenik JR, Yajnik V. Efficacy of Vedolizumab as Induction Therapy in Refractory IBD Patients: A Multicenter Cohort. Inflamm Bowel Dis. 2015 Dec; 21(12):2879-85. PMID: 26288002; PMCID: PMC4745906.
    Citations: 65     Fields:    Translation:Humans
  51. Allegretti JR, Borges L, Lucci M, Chang M, Cao B, Collins E, Vogel B, Arthur E, Emmons D, Korzenik JR. Risk Factors for Rehospitalization Within 90 Days in Patients with Inflammatory Bowel Disease. Inflamm Bowel Dis. 2015 Nov; 21(11):2583-9. PMID: 26244647; PMCID: PMC5189985.
    Citations: 25     Fields:    Translation:Humans
  52. Zhang S, Ermann J, Succi MD, Zhou A, Hamilton MJ, Cao B, Korzenik JR, Glickman JN, Vemula PK, Glimcher LH, Traverso G, Langer R, Karp JM. An inflammation-targeting hydrogel for local drug delivery in inflammatory bowel disease. Sci Transl Med. 2015 Aug 12; 7(300):300ra128. PMID: 26268315.
    Citations: 90     Fields:    Translation:HumansAnimalsCells
  53. Burakoff R, Pabby V, Onyewadume L, Odze R, Adackapara C, Wang W, Friedman S, Hamilton M, Korzenik J, Levine J, Makrauer F, Cheng C, Smith HC, Liew CC, Chao S. Blood-based biomarkers used to predict disease activity in Crohn's disease and ulcerative colitis. Inflamm Bowel Dis. 2015 May; 21(5):1132-40. PMID: 25895006.
    Citations: 17     Fields:    Translation:Humans
  54. Kuo B, Bhasin M, Jacquart J, Scult MA, Slipp L, Riklin EI, Lepoutre V, Comosa N, Norton BA, Dassatti A, Rosenblum J, Thurler AH, Surjanhata BC, Hasheminejad NN, Kagan L, Slawsby E, Rao SR, Macklin EA, Fricchione GL, Benson H, Libermann TA, Korzenik J, Denninger JW. Genomic and clinical effects associated with a relaxation response mind-body intervention in patients with irritable bowel syndrome and inflammatory bowel disease. PLoS One. 2015; 10(4):e0123861. PMID: 25927528.
    Citations: 35     Fields:    Translation:HumansCellsCTClinical Trials
  55. Juillerat P, Sokol H, Froehlich F, Yajnik V, Beaugerie L, Lucci M, Burnand B, Macpherson AJ, Cosnes J, Korzenik JR. Factors associated with durable response to infliximab in Crohn's disease 5 years and beyond: a multicenter international cohort. Inflamm Bowel Dis. 2015 Jan; 21(1):60-70. PMID: 25517594.
    Citations: 12     Fields:    Translation:Humans
  56. Allegretti JR, Korzenik JR, Hamilton MJ. Fecal microbiota transplantation via colonoscopy for recurrent C. difficile Infection. J Vis Exp. 2014 Dec 08; (94). PMID: 25549239; PMCID: PMC4396937.
    Citations: 15     Fields:    Translation:HumansCells
  57. Sauk J, Nguyen D, Yajnik V, Khalili H, Konijeti G, Hodin R, Bordeianou L, Shellito P, Sylla P, Korzenik J, Friedman S, Ananthakrishnan AN. Natural history of perianal Crohn's disease after fecal diversion. Inflamm Bowel Dis. 2014 Dec; 20(12):2260-5. PMID: 25230164.
    Citations: 13     Fields:    Translation:Humans
  58. Langhorst J, Wulfert H, Lauche R, Klose P, Cramer H, Dobos GJ, Korzenik J. Systematic review of complementary and alternative medicine treatments in inflammatory bowel diseases. J Crohns Colitis. 2015 Jan; 9(1):86-106. PMID: 25518050.
    Citations: 55     Fields:    Translation:Humans
  59. de Silva P, Korzenik J. The changing epidemiology of inflammatory bowel disease: identifying new high-risk populations. Clin Gastroenterol Hepatol. 2015 Apr; 13(4):690-2. PMID: 25451560.
    Citations: 4     Fields:    Translation:Humans
  60. Meelu P, Marin R, Clish C, Zella G, Cox S, Yajnik V, Nguyen DD, Korzenik JR. Impaired innate immune function associated with fecal supernatant from Crohn's disease patients: insights into potential pathogenic role of the microbiome. Inflamm Bowel Dis. 2014 Jul; 20(7):1139-46. PMID: 24892965.
    Citations: 2     Fields:    Translation:HumansCells
  61. Fowler SA, Ananthakrishnan AN, Gardet A, Stevens CR, Korzenik JR, Sands BE, Daly MJ, Xavier RJ, Yajnik V. SMAD3 gene variant is a risk factor for recurrent surgery in patients with Crohn's disease. J Crohns Colitis. 2014 Aug; 8(8):845-51. PMID: 24461721.
    Citations: 20     Fields:    Translation:Humans
  62. O'Toole A, Korzenik J. Environmental triggers for IBD. Curr Gastroenterol Rep. 2014; 16(7):396. PMID: 25048010.
    Citations: 14     Fields:    Translation:HumansPHPublic Health
  63. Ravikoff Allegretti J, Courtwright A, Lucci M, Korzenik JR, Levine J. Marijuana use patterns among patients with inflammatory bowel disease. Inflamm Bowel Dis. 2013 Dec; 19(13):2809-14. PMID: 24185313.
    Citations: 48     Fields:    Translation:HumansAnimals
  64. Khalili H, Ananthakrishnan AN, Konijeti GG, Liao X, Higuchi LM, Fuchs CS, Spiegelman D, Richter JM, Korzenik JR, Chan AT. Physical activity and risk of inflammatory bowel disease: prospective study from the Nurses' Health Study cohorts. BMJ. 2013 Nov 14; 347:f6633. PMID: 24231178; PMCID: PMC3935281.
    Citations: 48     Fields:    Translation:Humans
  65. Kelstrup AM, Juillerat P, Korzenik J. The accuracy of self-reported medical history: a preliminary analysis of the promise of internet-based research in Inflammatory Bowel Diseases. J Crohns Colitis. 2014 May; 8(5):349-56. PMID: 24183653.
    Citations: 15     Fields:    Translation:Humans
  66. Juillerat P, Wasan SK, Fowler SA, Friedman S, Pabby VK, Coukas JA, Barto AE, Pellish R, Germansky KA, Cheifetz AS, Korzenik JR, Farraye FA, Yajnik V. Efficacy and safety of natalizumab in Crohn's disease patients treated at 6 Boston academic hospitals. Inflamm Bowel Dis. 2013 Oct; 19(11):2457-63. PMID: 23962896.
    Citations: 11     Fields:    Translation:Humans
  67. Ananthakrishnan AN, Khalili H, Konijeti GG, Higuchi LM, de Silva P, Korzenik JR, Fuchs CS, Willett WC, Richter JM, Chan AT. A prospective study of long-term intake of dietary fiber and risk of Crohn's disease and ulcerative colitis. Gastroenterology. 2013 Nov; 145(5):970-7. PMID: 23912083; PMCID: PMC3805714.
    Citations: 207     Fields:    Translation:Humans
  68. Knutson CG, Mangerich A, Zeng Y, Raczynski AR, Liberman RG, Kang P, Ye W, Prestwich EG, Lu K, Wishnok JS, Korzenik JR, Wogan GN, Fox JG, Dedon PC, Tannenbaum SR. Chemical and cytokine features of innate immunity characterize serum and tissue profiles in inflammatory bowel disease. Proc Natl Acad Sci U S A. 2013 Jun 25; 110(26):E2332-41. PMID: 23754421.
    Citations: 51     Fields:    Translation:HumansAnimalsCells
  69. Oxford EC, Nguyen DD, Sauk J, Korzenik JR, Yajnik V, Friedman S, Ananthakrishnan AN. Impact of coexistent celiac disease on phenotype and natural history of inflammatory bowel diseases. Am J Gastroenterol. 2013 Jul; 108(7):1123-9. PMID: 23419379.
    Citations: 22     Fields:    Translation:Humans
  70. Desai A, Zator ZA, de Silva P, Nguyen DD, Korzenik J, Yajnik V, Ananthakrishnan AN. Older age is associated with higher rate of discontinuation of anti-TNF therapy in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2013 Feb; 19(2):309-15. PMID: 22605668.
    Citations: 52     Fields:    Translation:Humans
  71. Ananthakrishnan AN, Korzenik JR, Hur C. Can mucosal healing be a cost-effective endpoint for biologic therapy in Crohn's disease? A decision analysis. Inflamm Bowel Dis. 2013 Jan; 19(1):37-44. PMID: 22416019.
    Citations: 19     Fields:    Translation:Humans
  72. de Silva PS, Nguyen DD, Sauk J, Korzenik J, Yajnik V, Ananthakrishnan AN. Long-term outcome of a third anti-TNF monoclonal antibody after the failure of two prior anti-TNFs in inflammatory bowel disease. Aliment Pharmacol Ther. 2012 Sep; 36(5):459-66. PMID: 22784296.
    Citations: 18     Fields:    Translation:Humans
  73. Papa E, Docktor M, Smillie C, Weber S, Preheim SP, Gevers D, Giannoukos G, Ciulla D, Tabbaa D, Ingram J, Schauer DB, Ward DV, Korzenik JR, Xavier RJ, Bousvaros A, Alm EJ. Non-invasive mapping of the gastrointestinal microbiota identifies children with inflammatory bowel disease. PLoS One. 2012; 7(6):e39242. PMID: 22768065.
    Citations: 134     Fields:    Translation:Humans
  74. Juillerat P, Schneeweiss S, Cook EF, Ananthakrishnan AN, Mogun H, Korzenik JR. Drugs that inhibit gastric acid secretion may alter the course of inflammatory bowel disease. Aliment Pharmacol Ther. 2012 Aug; 36(3):239-47. PMID: 22670722.
    Citations: 16     Fields:    Translation:Humans
  75. Morgan XC, Tickle TL, Sokol H, Gevers D, Devaney KL, Ward DV, Reyes JA, Shah SA, LeLeiko N, Snapper SB, Bousvaros A, Korzenik J, Sands BE, Xavier RJ, Huttenhower C. Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol. 2012 Apr 16; 13(9):R79. PMID: 23013615.
    Citations: 1149     Fields:    Translation:HumansCells
  76. Ravikoff JE, Cole EB, Korzenik JR. Barriers to enrollment in inflammatory bowel disease randomized controlled trials: an investigation of patient perspectives. Inflamm Bowel Dis. 2012 Nov; 18(11):2092-8. PMID: 22241674.
    Citations: 10     Fields:    Translation:Humans
  77. Ananthakrishnan AN, Khalili H, Higuchi LM, Bao Y, Korzenik JR, Giovannucci EL, Richter JM, Fuchs CS, Chan AT. Higher predicted vitamin D status is associated with reduced risk of Crohn's disease. Gastroenterology. 2012 Mar; 142(3):482-9. PMID: 22155183; PMCID: PMC3367959.
    Citations: 166     Fields:    Translation:Humans
  78. Tinsley A, Macklin EA, Korzenik JR, Sands BE. Validation of the functional assessment of chronic illness therapy-fatigue (FACIT-F) in patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2011 Dec; 34(11-12):1328-36. PMID: 21999576.
    Citations: 24     Fields:    Translation:Humans
  79. Cullen G, Kroshinsky D, Cheifetz AS, Korzenik JR. Psoriasis associated with anti-tumour necrosis factor therapy in inflammatory bowel disease: a new series and a review of 120 cases from the literature. Aliment Pharmacol Ther. 2011 Dec; 34(11-12):1318-27. PMID: 21957906.
    Citations: 40     Fields:    Translation:Humans
  80. Ananthakrishnan AN, Hur C, Korzenik JR. Certolizumab pegol compared to natalizumab in patients with moderate to severe Crohn's disease: results of a decision analysis. Dig Dis Sci. 2012 Feb; 57(2):472-80. PMID: 21909990.
    Citations: 8     Fields:    Translation:Humans
  81. Ananthakrishnan AN, Hur C, Juillerat P, Korzenik JR. Strategies for the prevention of postoperative recurrence in Crohn's disease: results of a decision analysis. Am J Gastroenterol. 2011 Nov; 106(11):2009-17. PMID: 21788991.
    Citations: 14     Fields:    Translation:HumansPHPublic Health
  82. Cullen G, Bader C, Korzenik JR, Sands BE. Serological response to the 2009 H1N1 influenza vaccination in patients with inflammatory bowel disease. Gut. 2012 Mar; 61(3):385-91. PMID: 21757451.
    Citations: 49     Fields:    Translation:HumansCells
  83. Bordeianou L, Stein SL, Ho VP, Dursun A, Sands BE, Korzenik JR, Hodin RA. Immediate versus tailored prophylaxis to prevent symptomatic recurrences after surgery for ileocecal Crohn's disease? Surgery. 2011 Jan; 149(1):72-8. PMID: 20434748.
    Citations: 12     Fields:    Translation:HumansPHPublic Health
  84. Subramanian S, Yajnik V, Sands BE, Cullen G, Korzenik JR. Characterization of patients with infliximab-induced lupus erythematosus and outcomes after retreatment with a second anti-TNF agent. Inflamm Bowel Dis. 2011 Jan; 17(1):99-104. PMID: 20629183.
    Citations: 10     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
  85. Gardet A, Benita Y, Li C, Sands BE, Ballester I, Stevens C, Korzenik JR, Rioux JD, Daly MJ, Xavier RJ, Podolsky DK. LRRK2 is involved in the IFN-gamma response and host response to pathogens. J Immunol. 2010 Nov 01; 185(9):5577-85. PMID: 20921534; PMCID: PMC3156100.
    Citations: 188     Fields:    Translation:HumansAnimalsCells
  86. Zella GC, Hait EJ, Glavan T, Gevers D, Ward DV, Kitts CL, Korzenik JR. Distinct microbiome in pouchitis compared to healthy pouches in ulcerative colitis and familial adenomatous polyposis. Inflamm Bowel Dis. 2011 May; 17(5):1092-100. PMID: 20845425.
    Citations: 30     Fields:    Translation:HumansCells
  87. Kaplan GG, Hubbard J, Korzenik J, Sands BE, Panaccione R, Ghosh S, Wheeler AJ, Villeneuve PJ. The inflammatory bowel diseases and ambient air pollution: a novel association. Am J Gastroenterol. 2010 Nov; 105(11):2412-9. PMID: 20588264.
    Citations: 77     Fields:    Translation:HumansPHPublic Health
  88. Surolia I, Pirnie SP, Chellappa V, Taylor KN, Cariappa A, Moya J, Liu H, Bell DW, Driscoll DR, Diederichs S, Haider K, Netravali I, Le S, Elia R, Dow E, Lee A, Freudenberg J, De Jager PL, Chretien Y, Varki A, MacDonald ME, Gillis T, Behrens TW, Bloch D, Collier D, Korzenik J, Podolsky DK, Hafler D, Murali M, Sands B, Stone JH, Gregersen PK, Pillai S. Functionally defective germline variants of sialic acid acetylesterase in autoimmunity. Nature. 2010 Jul 08; 466(7303):243-7. PMID: 20555325.
    Citations: 81     Fields:    Translation:HumansAnimalsCells
  89. Sandborn WJ, Korzenik J, Lashner B, Leighton JA, Mahadevan U, Marion JF, Safdi M, Sninsky CA, Patel RM, Friedenberg KA, Dunnmon P, Ramsey D, Kane S. Once-daily dosing of delayed-release oral mesalamine (400-mg tablet) is as effective as twice-daily dosing for maintenance of remission of ulcerative colitis. Gastroenterology. 2010 Apr; 138(4):1286-96, 1296.e1-3. PMID: 20064514.
    Citations: 31     Fields:    Translation:Humans
  90. Faughnan ME, Palda VA, Garcia-Tsao G, Geisthoff UW, McDonald J, Proctor DD, Spears J, Brown DH, Buscarini E, Chesnutt MS, Cottin V, Ganguly A, Gossage JR, Guttmacher AE, Hyland RH, Kennedy SJ, Korzenik J, Mager JJ, Ozanne AP, Piccirillo JF, Picus D, Plauchu H, Porteous ME, Pyeritz RE, Ross DA, Sabba C, Swanson K, Terry P, Wallace MC, Westermann CJ, White RI, Young LH, Zarrabeitia R. International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia. J Med Genet. 2011 Feb; 48(2):73-87. PMID: 19553198.
    Citations: 286     Fields:    Translation:Humans
  91. Schneeweiss S, Korzenik J, Solomon DH, Canning C, Lee J, Bressler B. Infliximab and other immunomodulating drugs in patients with inflammatory bowel disease and the risk of serious bacterial infections. Aliment Pharmacol Ther. 2009 Aug; 30(3):253-64. PMID: 19438424.
    Citations: 76     Fields:    Translation:Humans
  92. Engelbrektson A, Korzenik JR, Pittler A, Sanders ME, Klaenhammer TR, Leyer G, Kitts CL. Probiotics to minimize the disruption of faecal microbiota in healthy subjects undergoing antibiotic therapy. J Med Microbiol. 2009 May; 58(Pt 5):663-670. PMID: 19369530.
    Citations: 30     Fields:    Translation:HumansCells
  93. Lam MY, Lee H, Bright R, Korzenik JR, Sands BE. Validation of interactive voice response system administration of the Short Inflammatory Bowel Disease Questionnaire. Inflamm Bowel Dis. 2009 Apr; 15(4):599-607. PMID: 19023897.
    Citations: 12     Fields:    Translation:Humans
  94. Hait EJ, Barendse RM, Arnold JH, Valim C, Sands BE, Korzenik JR, Fishman LN. Transition of adolescents with inflammatory bowel disease from pediatric to adult care: a survey of adult gastroenterologists. J Pediatr Gastroenterol Nutr. 2009 Jan; 48(1):61-5. PMID: 19172125.
    Citations: 40     Fields:    Translation:Humans
  95. Korzenik JR. Diverticulitis: new frontiers for an old country: risk factors and pathogenesis. J Clin Gastroenterol. 2008 Nov-Dec; 42(10):1128-9. PMID: 18936649.
    Citations: 4     Fields:    Translation:Humans
  96. Korzenik JR. Flare factor: are there any triggering factors associated with onset of clinical symptoms or disease relapse? Inflamm Bowel Dis. 2008 Oct; 14 Suppl 2:S150-1. PMID: 18816722.
    Citations:    Fields:    Translation:Humans
  97. Kaplan GG, Jackson T, Sands BE, Frisch M, Andersson RE, Korzenik J. The risk of developing Crohn's disease after an appendectomy: a meta-analysis. Am J Gastroenterol. 2008 Nov; 103(11):2925-31. PMID: 18775018.
    Citations: 40     Fields:    Translation:Humans
  98. Kunitake H, Hodin R, Shellito PC, Sands BE, Korzenik J, Bordeianou L. Perioperative treatment with infliximab in patients with Crohn's disease and ulcerative colitis is not associated with an increased rate of postoperative complications. J Gastrointest Surg. 2008 Oct; 12(10):1730-6; discussion 1736-7. PMID: 18709514.
    Citations: 61     Fields:    Translation:Humans
  99. Kaplan GG, McCarthy EP, Ayanian JZ, Korzenik J, Hodin R, Sands BE. Impact of hospital volume on postoperative morbidity and mortality following a colectomy for ulcerative colitis. Gastroenterology. 2008 Mar; 134(3):680-7. PMID: 18242604.
    Citations: 82     Fields:    Translation:Humans
  100. Kaplan GG, Hur C, Korzenik J, Sands BE. Infliximab dose escalation vs. initiation of adalimumab for loss of response in Crohn's disease: a cost-effectiveness analysis. Aliment Pharmacol Ther. 2007 Dec; 26(11-12):1509-20. PMID: 17931345.
    Citations: 23     Fields:    Translation:Humans
  101. Kaplan GG, Pedersen BV, Andersson RE, Sands BE, Korzenik J, Frisch M. The risk of developing Crohn's disease after an appendectomy: a population-based cohort study in Sweden and Denmark. Gut. 2007 Oct; 56(10):1387-92. PMID: 17494106; PMCID: PMC2000241.
    Citations: 26     Fields:    Translation:Humans
  102. Korzenik J. The role of innate immunity in Crohn's disease. Gastroenterol Hepatol (N Y). 2007 Feb; 3(2):82-3. PMID: 21960814.
  103. Korzenik JR. Is Crohn's disease due to defective immunity? Gut. 2007 Jan; 56(1):2-5. PMID: 17172582; PMCID: PMC1856647.
    Citations: 26     Fields:    Translation:HumansCells
  104. Bishnupuri KS, Luo Q, Korzenik JR, Henderson JO, Houchen CW, Anant S, Dieckgraefe BK. Dysregulation of Reg gene expression occurs early in gastrointestinal tumorigenesis and regulates anti-apoptotic genes. Cancer Biol Ther. 2006 Dec; 5(12):1714-20. PMID: 17106246.
    Citations: 15     Fields:    Translation:HumansAnimalsCells
  105. Yamamoto-Furusho JK, Korzenik JR. Crohn's disease: innate immunodeficiency? World J Gastroenterol. 2006 Nov 14; 12(42):6751-5. PMID: 17106921; PMCID: PMC4087427.
    Citations: 11     Fields:    Translation:HumansCells
  106. Engelbrektson AL, Korzenik JR, Sanders ME, Clement BG, Leyer G, Klaenhammer TR, Kitts CL. Analysis of treatment effects on the microbial ecology of the human intestine. FEMS Microbiol Ecol. 2006 Aug; 57(2):239-50. PMID: 16867142.
    Citations: 17     Fields:    Translation:HumansCells
  107. Dieckgraefe BK, Korzenik JR, Anant S. Growth factors as treatment options for intestinal inflammation. Ann N Y Acad Sci. 2006 Aug; 1072:300-6. PMID: 17057209.
    Citations: 7     Fields:    Translation:Animals
  108. Korzenik JR. Case closed? Diverticulitis: epidemiology and fiber. J Clin Gastroenterol. 2006 Aug; 40 Suppl 3:S112-6. PMID: 16885692.
    Citations: 21     Fields:    Translation:Humans
  109. Siegel CA, Hur C, Korzenik JR, Gazelle GS, Sands BE. Risks and benefits of infliximab for the treatment of Crohn's disease. Clin Gastroenterol Hepatol. 2006 Aug; 4(8):1017-24; quiz 976. PMID: 16843733.
    Citations: 29     Fields:    Translation:Humans
  110. Kradin RL, Badizadegan K, Auluck P, Korzenik J, Lauwers GY. Iatrogenic Trichuris suis infection in a patient with Crohn disease. Arch Pathol Lab Med. 2006 May; 130(5):718-20. PMID: 16683891.
    Citations: 20     Fields:    Translation:HumansAnimalsCells
  111. Korzenik JR, Podolsky DK. Evolving knowledge and therapy of inflammatory bowel disease. Nat Rev Drug Discov. 2006 Mar; 5(3):197-209. PMID: 16518373.
    Citations: 41     Fields:    Translation:HumansAnimalsCells
  112. Korzenik JR, Podolsky DK. Selective use of selective nonsteroidal anti-inflammatory drugs in inflammatory bowel disease. Clin Gastroenterol Hepatol. 2006 Feb; 4(2):157-9. PMID: 16469674.
    Citations: 5     Fields:    Translation:Humans
  113. Korzenik J, Chung DC, Digumarthy S, Badizadegan K. Case records of the Massachusetts General Hospital. Case 33-2005. A 43-year-old man with lower gastrointestinal bleeding. N Engl J Med. 2005 Oct 27; 353(17):1836-44. PMID: 16251540.
    Citations: 1     Fields:    Translation:Humans
  114. Lawrence SJ, Korzenik JR, Mundy LM. Probiotics for recurrent Clostridium difficile disease. J Med Microbiol. 2005 Sep; 54(Pt 9):905-906. PMID: 16091446.
    Citations: 31     Fields:    Translation:HumansCellsPHPublic HealthCTClinical Trials
  115. Korzenik JR, Dieckgraefe BK, Valentine JF, Hausman DF, Gilbert MJ. Sargramostim for active Crohn's disease. N Engl J Med. 2005 May 26; 352(21):2193-201. PMID: 15917384.
    Citations: 109     Fields:    Translation:HumansCTClinical Trials
  116. Korzenik JR. Past and current theories of etiology of IBD: toothpaste, worms, and refrigerators. J Clin Gastroenterol. 2005 Apr; 39(4 Suppl 2):S59-65. PMID: 15758661.
    Citations: 33     Fields:    Translation:HumansCells
  117. Korzenik JR, Dieckgraefe BK. An open-labelled study of granulocyte colony-stimulating factor in the treatment of active Crohn's disease. Aliment Pharmacol Ther. 2005 Feb 15; 21(4):391-400. PMID: 15709989.
    Citations: 30     Fields:    Translation:HumansCTClinical Trials
  118. Korzenik JR. Crohn's disease: future anti-tumor necrosis factor therapies beyond infliximab. Gastroenterol Clin North Am. 2004 Jun; 33(2):285-301, ix. PMID: 15177539.
    Citations: 3     Fields:    Translation:Humans
  119. Sands BE, Anderson FH, Bernstein CN, Chey WY, Feagan BG, Fedorak RN, Kamm MA, Korzenik JR, Lashner BA, Onken JE, Rachmilewitz D, Rutgeerts P, Wild G, Wolf DC, Marsters PA, Travers SB, Blank MA, van Deventer SJ. Infliximab maintenance therapy for fistulizing Crohn's disease. N Engl J Med. 2004 Feb 26; 350(9):876-85. PMID: 14985485.
    Citations: 522     Fields:    Translation:HumansCTClinical Trials
  120. Dieckgraefe BK, Korzenik JR. Treatment of active Crohn's disease with recombinant human granulocyte-macrophage colony-stimulating factor. Lancet. 2002 Nov 09; 360(9344):1478-80. PMID: 12433518.
    Citations: 61     Fields:    Translation:HumansCTClinical Trials
  121. Dieckgraefe BK, Korzenik JR, Husain A, Dieruf L. Association of glycogen storage disease 1b and Crohn disease: results of a North American survey. Eur J Pediatr. 2002 Oct; 161 Suppl 1:S88-92. PMID: 12373579.
    Citations: 38     Fields:    Translation:Humans
  122. Krishnan A, Korzenik JR. Inflammatory bowel disease and environmental influences. Gastroenterol Clin North Am. 2002 Mar; 31(1):21-39. PMID: 12122733.
    Citations: 9     Fields:    Translation:HumansPHPublic Health
  123. Dieckgraefe BK, Stenson WF, Korzenik JR, Swanson PE, Harrington CA. Analysis of mucosal gene expression in inflammatory bowel disease by parallel oligonucleotide arrays. Physiol Genomics. 2000 Nov 09; 4(1):1-11. PMID: 11074008.
    Citations: 70     Fields:    Translation:HumansCells
  124. Garcia-Tsao G, Korzenik JR, Young L, Henderson KJ, Jain D, Byrd B, Pollak JS, White RI. Liver disease in patients with hereditary hemorrhagic telangiectasia. N Engl J Med. 2000 Sep 28; 343(13):931-6. PMID: 11006369.
    Citations: 79     Fields:    Translation:Humans
  125. Whiting JH, Korzenik JR, Miller FJ, Pollack JS, White RI. Fatal outcome after embolotherapy for hepatic arteriovenous malformations of the liver in two patients with hereditary hemorrhagic telangiectasia. J Vasc Interv Radiol. 2000 Jul-Aug; 11(7):855-8. PMID: 10928521.
    Citations: 8     Fields:    Translation:HumansCells
  126. Korzenik JR, Dieckgraefe BK. Is Crohn's disease an immunodeficiency? A hypothesis suggesting possible early events in the pathogenesis of Crohn's disease. Dig Dis Sci. 2000 Jun; 45(6):1121-9. PMID: 10877227.
    Citations: 32     Fields:    Translation:HumansCells
  127. Korzenik JR. Infliximab for fistulas: a hole in one? Inflamm Bowel Dis. 2000 Feb; 6(1):62-3. PMID: 10701153.
    Citations:    Fields:    Translation:HumansCTClinical Trials
  128. Miller FJ, Whiting JH, Korzenik JR, White RI. Caution with use of hepatic embolization in the treatment of hereditary hemorrhagic telangiectasia. Radiology. 1999 Dec; 213(3):928-30. PMID: 10580979.
    Citations: 3     Fields:    Translation:Humans
  129. Lee JY, Korzenik JR, DeMasi R, Lih-Brody L, White RI. Transjugular intrahepatic portosystemic shunts in patients with hereditary hemorrhagic telangiectasia: failure to palliate gastrointestinal bleeding. J Vasc Interv Radiol. 1998 Nov-Dec; 9(6):994-7. PMID: 9840048.
    Citations: 2     Fields:    Translation:Humans
  130. Krinsky ML, Robert ME, Garcia JC, Korzenik JR, Topazian M. Polypoid vascular malformations of the small intestine. Gastrointest Endosc. 1998 Nov; 48(5):530-3. PMID: 9831847.
    Citations: 1     Fields:    Translation:Humans
  131. Korzenik JR, Hsu A, Robert ME. Effect of heparin on dextran sulfate sodium-induced colitis. Dig Dis Sci. 1998 Aug; 43(8):1800-5. PMID: 9724172.
    Citations: 4     Fields:    Translation:Animals
  132. Ullman T, Korzenik JR. Yogurt as oral bacteriotherapy for diarrhea: back to the future? Indian Pediatr. 1998 Jun; 35(6):503-6. PMID: 10216643.
    Citations:    Fields:    Translation:Humans
  133. Husain A, Korzenik JR. Nutritional issues and therapy in inflammatory bowel disease. Semin Gastrointest Dis. 1998 Jan; 9(1):21-30. PMID: 9547853.
    Citations: 7     Fields:    Translation:Humans
  134. Saito K, Korzenik JR, Jekel JF, Bhattacharji S. A case-control study of maternal knowledge of malnutrition and health-care-seeking attitudes in rural South India. Yale J Biol Med. 1997 Mar-Apr; 70(2):149-60. PMID: 9493847; PMCID: PMC2589065.
    Citations: 14     Fields:    Translation:Humans
  135. Korzenik JR. IBD: A Vascular Disorder? The Case for Heparin Therapy. Inflamm Bowel Dis. 1997; 3(2):87-94. PMID: 23282750.
    Citations: 6     Fields:    
  136. Korzenik JR. Hereditary hemorrhagic telangiectasia and other intestinal vascular anomalies. Gastroenterologist. 1996 Sep; 4(3):203-10. PMID: 8891684.
    Citations: 4     Fields:    Translation:Humans
  137. Korzenik JR, Topazian MD, White R. Treatment of bleeding in hereditary hemorrhagic telangiectasia with aminocaproic acid. N Engl J Med. 1994 Nov 03; 331(18):1236. PMID: 7935675.
    Citations: 3     Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Korzenik's Networks
Click the
buttons for more information and interactive visualizations!
Concepts (535)
Co-Authors (96)
Similar People (60)
Same Department 
Physical Neighbors
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.